Vitamin C (ascorbic acid) is the world's most widely taken supplement. Linus Pauling's advocacy in the 1970s convinced generations that high-dose vitamin C prevented colds and cancer. The evidence has since complicated both claims considerably.
What remains is a genuinely important micronutrient with legitimate evidence for specific outcomes — not the ones most commonly marketed.
What vitamin C does
Ascorbic acid is a water-soluble vitamin and potent antioxidant. Key roles:
Collagen synthesis: Vitamin C is a cofactor for prolyl hydroxylase and lysyl hydroxylase — enzymes required to hydroxylate proline and lysine residues in collagen. Without adequate vitamin C, collagen cannot form its triple helix structure. Severe deficiency causes scurvy (collagen breakdown throughout the body).
Iron absorption: Reduces non-heme (plant-source) iron from Fe3+ to Fe2+, dramatically improving intestinal absorption. 100mg vitamin C with a plant-iron meal can increase absorption 2–6×.
Antioxidant: Donates electrons to neutralize free radicals in aqueous environments. Regenerates vitamin E after it donates electrons. Important in plasma and intracellular water.
Neurotransmitter synthesis: Required for dopamine β-hydroxylase (converts dopamine to norepinephrine) and carnitine synthesis (relevant to fatty acid metabolism).
Immune function: Accumulates in leukocytes at concentrations 50–100× plasma levels. Supports various immune cell functions.
The cold prevention myth — and what the evidence actually shows
The Cochrane Review on vitamin C and colds (Hemilä & Chalker, updated 2013, 29 trials, 11,306 participants) is the most comprehensive analysis:
Prevention in the general population: Regular vitamin C supplementation does NOT reduce cold incidence in the general population. This is definitive.
Prevention in people under extreme physical stress: Consistent 50% reduction in cold incidence in marathon runners, skiers, and soldiers during training. This is a real effect in a specific population under extreme cold exposure and exertion.
Duration when you do get a cold: Regular supplementation (not started at onset) reduces cold duration by:
- 8% in adults (~half a day shorter)
- 14% in children (~1 day shorter)
Severity: Modest reduction in symptom severity.
Therapeutic use (starting at cold onset): Cochrane found insufficient evidence to recommend vitamin C at cold onset for treatment. Some studies suggest benefit; the evidence is not consistent enough.
Conclusion: Vitamin C doesn't prevent colds for most people. It modestly shortens them. For athletes under heavy training loads and cold exposure, prevention evidence is stronger.
Cardiovascular evidence
Observational studies consistently show higher vitamin C status associated with lower cardiovascular disease risk. RCTs have been more mixed:
- HPFS and NHS cohort studies: Dietary vitamin C associated with significantly lower cardiovascular mortality
- Heart Protection Study (MRC/BHF): Antioxidant combination (including vitamin C) showed no cardiovascular benefit
- Meta-analyses: Dietary vitamin C reduces CVD risk; supplemental vitamin C shows weaker, inconsistent effects
The likely explanation: dietary vitamin C comes with flavonoids, fiber, and other compounds in fruits and vegetables. Isolated ascorbic acid doesn't capture this package.
Collagen synthesis — the legitimate sports application
This is increasingly relevant in sports medicine:
Shaw et al. (2017): 15g gelatin + 48mg vitamin C taken 60 minutes before 6 minutes of jump rope significantly increased collagen synthesis markers in tendons vs. placebo.
The mechanism: vitamin C is rate-limiting for the hydroxylation steps in collagen synthesis. If vitamin C is even slightly suboptimal, collagen formation slows.
Practical implication: Taking 50–100mg vitamin C with collagen supplementation before exercise sessions targeting tendon/ligament health is mechanistically justified. This is now a standard protocol in some sports medicine programs.
Cancer — where Pauling was wrong
Linus Pauling claimed high-dose vitamin C (10g/day) treated and prevented cancer. He died of prostate cancer.
Oral supplementation: The CARET, ATBC, and multiple large RCTs found no cancer prevention benefit from oral vitamin C supplementation. Some studies suggested increased risk in specific subgroups (smokers + beta-carotene, but not vitamin C specifically).
Intravenous (IV) high-dose vitamin C: Different story. At pharmacological IV doses, plasma vitamin C reaches concentrations that are toxic to tumor cells via hydrogen peroxide production — a mechanism not achievable with oral supplementation (absorption is saturated). Several clinical trials show IV vitamin C as adjunct cancer therapy may improve quality of life and potentially extend survival. This is active research territory. Not available from a supplement store.
Antioxidant and exercise — the interference problem
Like other antioxidants, high-dose vitamin C can blunt exercise adaptations:
Ristow et al. (2009, PNAS): 1,000mg vitamin C + 400 IU vitamin E daily for 4 weeks blunted mitochondrial biogenesis and insulin sensitivity improvements from endurance training vs. placebo.
Reactive oxygen species (ROS) are not purely harmful — they're signaling molecules that trigger adaptations. Scavenging them with high-dose antioxidants can reduce the training stimulus.
Practical guidance: Avoid high-dose vitamin C (>500mg) within a few hours of endurance or resistance training during adaptation phases.
Absorption and bioavailability
Vitamin C absorption is dose-dependent:
- 200mg: ~100% absorbed
- 1,000mg: ~67% absorbed
- 2,000mg: ~33% absorbed
- Excess excreted in urine (osmotic laxative effect at high doses)
Plasma vitamin C saturates at about 200–400mg/day in healthy adults. Higher doses don't produce proportionally higher plasma levels.
RDA: 75mg (women), 90mg (men). Smokers need 35mg more (oxidative stress depletes it faster).
Scurvy prevention: As little as 10mg/day. RDA is the saturation target, not the minimum.
Optimal range: 200–400mg/day from diet + supplementation covers plasma saturation. Higher doses have limited additional benefit for most people.
Kidney stone risk
High-dose vitamin C (>2,000mg/day) is metabolized partly to oxalate. In susceptible individuals, this increases kidney stone risk (calcium oxalate stones). People with history of kidney stones, hyperoxaluria, or renal insufficiency should limit supplementation to ≤500mg/day.
Whole food vs. supplement
The best vitamin C sources are fruits and vegetables — bell peppers (120–190mg per cup), citrus (70–95mg), kiwi (64mg each), broccoli (85mg per cup).
Dietary vitamin C comes with flavonoids and phytonutrients that may enhance its activity. The cardiovascular benefit gap between dietary and supplemental vitamin C suggests this context matters.
The framework applied
For any vitamin C study:
- What dose? RDA-level vs. gram-level doses have different evidence bases and different risks
- Oral vs. IV? Completely different pharmacokinetics and mechanisms
- Was exercise controlled? High-dose during training can blunt adaptations
- What outcome? Cold prevention vs. duration vs. collagen vs. cardiovascular vs. cancer are four separate evidence stories
- Was dietary intake assessed? Supplementation studies in vitamin C-replete populations show smaller effects
We automated this at Q-SCI. Any study — paste it, get a quality score.
Bottom line
- Vitamin C does NOT prevent colds in the general population — this is settled; it shortens them by about half a day
- Real evidence for: collagen synthesis (take with collagen pre-exercise), iron absorption (take with plant-iron meals), extreme athlete immune support
- Cardiovascular benefit is mostly from dietary vitamin C with fruits and vegetables, not isolated supplementation
- High-dose (>500mg) blunts training adaptations — avoid around workouts
- 200–400mg/day covers plasma saturation; higher doses mostly go to urine
- Kidney stone risk with chronic >2,000mg/day
- Eat the bell peppers and kiwi. Supplement 100–250mg if dietary intake is low.
Vitamin C is essential and the deficiency evidence is clear. The high-dose supplementation story is mostly marketing that the evidence doesn't support.
More evidence-based analyses at q-sci.org/blog. Score studies free at q-sci.org.
Top comments (0)